title: Reply to the letter to the editor 'The link between type 2 diabetes and pancreatic adenocarcinoma is yet to be established' by Rahman and Meeran.
authors.affiliation: Department of Epidemiology, IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy;. Electronic address: cristina.bosetti@marionegri.it.
authors.forename: C
authors.initials: C
authors.lastname: Bosetti
authors.affiliation: Department of Health Sciences Research, Medicine and Medical Genetics, Mayo Clinic, Rochester.
authors.forename: G M
authors.initials: GM
authors.lastname: Petersen
authors.affiliation: Department of Gastrointestinal Medical Oncology, UT M.D. Anderson Cancer Center, University of Texas, Houston, USA.
authors.forename: D
authors.initials: D
authors.lastname: Li
authors.affiliation: Departments of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy.
authors.forename: C
authors.initials: C
authors.lastname: La Vecchia
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008297:Male; D010190:Pancreatic Neoplasms / Q000453:epidemiology*
chemical_list: D007004:Hypoglycemic Agents